By Anthony Rivas | Mon, 06/02/2014 - 18:12
Chronic cerebrospinal venous insufficiency has been tested as a possible cause for multiple sclerosis since 2009. A new study now finds that the controversial theory stands no ground.
By Anthony Rivas | Mon, 05/19/2014 - 15:14
Marijuana is making a record comeback in the U.S., and much of it is thanks to its ability to help people with certain illnesses.
By Anthony Rivas | Sun, 03/23/2014 - 19:09
The progression of an advanced stage of multiple sclerosis, which currently has few — if any — treatment options, was shown to slow down with the help of cholesterol-lowering drugs called statins.
By Susan Scutti | Fri, 02/21/2014 - 16:00
A new study has discovered a particular antibody that is found in the blood of people with MS may be present long before the onset of the disease and its symptoms.
By Jillian Rose Lim | Fri, 02/14/2014 - 15:00
New research suggests patients with MS are more likely to have an undiagnosed sleeping disorder, which could contribute to their fatigue.
By Lecia Bushak | Sat, 02/08/2014 - 16:11
A new potential MS treatment can use a the protein Endothelin-1 to help repair brain tissue damage.
By Susan Scutti | Wed, 01/29/2014 - 13:52
Biogen posted a 26 percent increase over last year’s annual revenues, an extraordinary surge due in part to the swift growth of Tecfidera, the company’s oral multiple sclerosis drug.
By John Ericson | Tue, 01/28/2014 - 16:57
A possible bacterial trigger for multiple sclerosis may allow researchers to develop vaccines and antibodies against the debilitating condition.
By Justin Caba | Mon, 01/06/2014 - 16:37
The amount of alcohol we consume has no effect on our risk of developing multiple sclerosis, according to a new study.